(NYSE: STE) Steris's forecast annual revenue growth rate of 5.96% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.03%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.31%.
Steris's revenue in 2025 is $5,702,501,000.On average, 11 Wall Street analysts forecast STE's revenue for 2026 to be $585,348,761,676, with the lowest STE revenue forecast at $557,867,599,156, and the highest STE revenue forecast at $611,946,601,115. On average, 10 Wall Street analysts forecast STE's revenue for 2027 to be $622,252,037,060, with the lowest STE revenue forecast at $591,532,023,243, and the highest STE revenue forecast at $651,205,404,715.
In 2028, STE is forecast to generate $668,184,837,272 in revenue, with the lowest revenue forecast at $643,648,085,022 and the highest revenue forecast at $707,443,640,872.